Eximo Medical

Company Overview

Snapshot

Founded in July 2012 by Ilan Ben Oren, Eximo Medical operates with 11–50 employees. The company raised $2.52M across 2 funding rounds from 4 investors. In October 2019, Eximo Medical was acquired by AngioDynamics.

Business overview

Eximo Medical develops hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications. Its proprietary single-use hybrid catheter, Auryon, integrates optical fibers for short laser pulses with a blunt mechanical knife. The Auryon system is designed to treat infrainguinal lesions, including those below the knee and ankle, featuring a built-in off-centering mechanism for eccentric lesions and aspiration capabilities to mitigate embolization risks. The company operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices, and serves clinics, doctors, and hospitals.

Strategic signal

In October 2019, AngioDynamics acquired Eximo Medical, signaling a strategic consolidation within the medical device industry. This acquisition highlights the value placed on innovative laser atherectomy technology for peripheral artery disease, suggesting a market trend towards integrating advanced, minimally invasive solutions into broader medical portfolios. For investors, this indicates a potential for exits in the specialized medical device segment and validates the commercial viability of Eximo Medical's Auryon system.

Company Intelligence Q&A

What was a significant corporate milestone for Eximo Medical?

Eximo Medical was acquired by AngioDynamics in October 2019, marking a key exit for the company and its investors.

When did Eximo Medical launch its B-Laser Atherectomy System?

Eximo Medical launched its B-Laser Atherectomy System in May 2019, as reported by Medical Design and Outsourcing.

When did Eximo Medical announce the first commercial case of its B-Laser Atherectomy System in the U.S.?

Eximo Medical announced the first commercial case of its B-Laser Atherectomy System in the U.S. in January 2019.

Which investors participated in Eximo Medical's Seed funding round?

In October 2012, Eximo Medical received Seed funding from Peregrine Ventures and Accel.

When did Eximo Medical's hybrid catheter clear its pivotal trial?

Eximo Medical's hybrid catheter cleared its pivotal trial in April 2016.